Level Chart

Level Chart

Basic Info

Boston Scientific Corp (BSX) - MedSurg Organic Revenue Growth is at 0.70%, compared to 5.40% last quarter and 7.60% last year. This is lower than the long term average of 7.59%.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 0.70%
Latest Period Sep 2026
Last Updated Oct 28 2026, 09:16 EDT
Next Release Feb 17 2027, 08:30 EST (E)
Long Term Average 7.59%
Average Growth Rate -93.38%
Value from Last Quarter 5.40%
Change from Last Quarter -87.04%
Value from 1 Year Ago 7.60%
Change from 1 Year Ago -90.79%
Frequency Quarterly
Unit Percent
Adjustment N/A
Download Source File

Historical Data

View and export this data back to 2019. Start Trial.
Date Value
September 30, 2026 0.70%
June 30, 2026 5.40%
March 31, 2026 5.70%
December 31, 2025 6.50%
September 30, 2025 7.60%
June 30, 2025 7.00%
March 31, 2025 5.30%
December 31, 2024 7.00%
September 30, 2024 7.70%
June 30, 2024 7.60%
March 31, 2024 7.80%
December 31, 2023 8.90%
September 30, 2023 9.40%
June 30, 2023 8.80%
Date Value
March 31, 2023 13.40%
December 31, 2022 8.50%
September 30, 2022 9.80%
June 30, 2022 4.80%
March 31, 2022 8.00%
December 31, 2021 9.40%
September 30, 2021 9.40%
June 30, 2021 60.70%
March 31, 2021 9.50%
December 31, 2020 1.10%
September 30, 2020 -1.90%
June 30, 2020 -28.40%
March 31, 2020 2.10%
December 31, 2019 10.60%

Basic Info

Boston Scientific Corp (BSX) - MedSurg Organic Revenue Growth is at 0.70%, compared to 5.40% last quarter and 7.60% last year. This is lower than the long term average of 7.59%.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 0.70%
Latest Period Sep 2026
Last Updated Oct 28 2026, 09:16 EDT
Next Release Feb 17 2027, 08:30 EST (E)
Long Term Average 7.59%
Average Growth Rate -93.38%
Value from Last Quarter 5.40%
Change from Last Quarter -87.04%
Value from 1 Year Ago 7.60%
Change from 1 Year Ago -90.79%
Frequency Quarterly
Unit Percent
Adjustment N/A
Download Source File

Related Securities

Symbol Name Change %
BSX Boston Scientific Corp. -2.35%